Sign in to view content

2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

Nancy M. Holekamp, MD, FASRS

Video
Published 2018

Related

Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Toxicity: RELIEF Trial Results
Karen M Wai, MD
STEPHEN J SMITH, MD
Updates from the Field
2025
Obstructive Sleep Apnea as a Risk Factor for Diabetic Retinopathy Progression and Systemic Complications
Ehsan Rahimy, MD
Annual Meeting Talks
2024
Acute Macular and Peripapillary Angiographic Changes With Intravitreal Injections
Alexander Barash, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more